Exercise Fights Chemo Brain Better Than Ibuprofen in New Clinical Trial
A home-based walking and resistance program improved attention and reduced observable cognitive decline in chemotherapy patients over 6 weeks.
Summary
Chemotherapy-related cognitive impairment, known as chemo brain, affects up to 80% of cancer patients undergoing treatment. A Phase II clinical trial tested whether a home-based exercise program, low-dose ibuprofen, or both could help preserve mental sharpness during chemotherapy. Eighty-six patients were randomly assigned to one of four groups for six weeks. Those who followed the exercise program showed significantly better attention scores and fewer cognitive problems noticed by friends and family compared to placebo. Ibuprofen offered some benefits but produced mixed results, including a surprising reduction in short-term verbal memory gains. Exercise emerged as the more reliable and consistent intervention for protecting cognitive function during chemotherapy treatment.
Detailed Summary
Cancer-related cognitive impairment affects the majority of people undergoing chemotherapy, causing memory lapses, trouble concentrating, and difficulty multitasking. Nicknamed chemo brain, this side effect can significantly reduce quality of life during and after treatment. A new Phase II clinical trial published in CANCER, a peer-reviewed journal of the American Cancer Society, suggests that a straightforward home-based exercise routine may help protect cognitive function during chemotherapy.
The trial enrolled 86 cancer patients who reported cognitive difficulties while receiving chemotherapy. Participants were randomized into four groups for six weeks: exercise plus low-dose ibuprofen, exercise plus placebo, ibuprofen only, or placebo only. The exercise intervention, called EXCAP, consisted of a progressively intensifying home-based walking and resistance training program requiring no gym access.
Patients in the exercise-plus-placebo group performed significantly better on attention tests than those receiving only placebo. Crucially, both exercise groups showed improvement on an observer-rated measure assessing whether friends, family, or coworkers noticed cognitive problems, suggesting real-world functional benefits beyond lab scores.
Ibuprofen produced a more complicated picture. While ibuprofen-only patients showed some attention improvements over placebo, those taking ibuprofen demonstrated less improvement in short-term verbal memory than non-ibuprofen groups. Researchers flag this finding as requiring further investigation and caution against drawing firm conclusions about ibuprofen's role at this stage.
The study is a Phase II trial, meaning it was designed to assess feasibility and signal detection rather than deliver definitive proof. Larger Phase III trials will be needed to confirm these findings across diverse cancer types and treatment regimens. Nevertheless, for health-conscious individuals navigating cancer treatment, the findings reinforce that low-to-moderate intensity exercise during chemotherapy is a low-risk, accessible strategy with meaningful cognitive benefits worth discussing with an oncologist.
Key Findings
- Home-based progressive walking and resistance exercise significantly improved attention scores in chemotherapy patients over 6 weeks.
- Both exercise groups showed reduced observer-noticed cognitive problems compared to placebo, indicating real-world functional improvement.
- Low-dose ibuprofen improved some attention measures but unexpectedly reduced short-term verbal memory gains, warranting further study.
- Up to 80% of chemotherapy patients experience chemo brain, making cognitive protection strategies a high-priority clinical need.
- Exercise required no gym access and was low-to-moderate intensity, making it feasible for most patients undergoing treatment.
Methodology
This is a research summary reporting on a peer-reviewed Phase II randomized controlled trial published in CANCER, a journal of the American Cancer Society. The source is Wiley via ScienceDaily, a credible science news aggregator. The study used a four-arm randomized design with 86 participants, providing preliminary but structured evidence.
Study Limitations
This is a Phase II trial with only 86 participants, limiting statistical power and generalizability across cancer types and chemotherapy regimens. The six-week duration may not reflect longer-term cognitive outcomes. The unexpected negative effect of ibuprofen on verbal memory is unexplained and requires replication before any clinical guidance can be issued.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.